Fertility Centers Of Illinois Seeks In Vitro Fertilization Patients For Clinical Trial Of Investigational Drug That Promotes Pregnancy
(cz) Fertility Centers of Illinois S.C., (FCI) along with several other large infertility practices nationwide, have been selected to participate in a Phase III Clinical Trial for an investigational drug that supports pregnancy and is used with In Vitro Fertilization (IVF). FCI seeks up to 200 patients to take part in the study and is offering one cycle of In Vitro Fertilization (IVF) at no cost to all that meet the study criteria.
All patients taking part in the study will be required to take daily injections of gonadotropins to prepare the eggs, similar to a typical IVF cycle. Half of patients will be randomized into a group taking the FDA approved drug and the other half will take the investigational drug. Randomization to the progesterone treatment group will occur after a patient has reached egg retrieval. more...
From: »Medical News Today«